Chris Griffith is a seasoned biopharma executive with over 20 years of experience in corporate development, strategy, and leadership within the biopharmaceutical industry. Currently serving as the Chief Business & Strategy Officer at Vaxcyte, Chris has a successful track record that includes co-founding Dermira, which was sold for over $1 billion, and advancing numerous R&D programs across various therapeutic areas. They hold a BS and MS in Biological Sciences from Stanford University and an MBA from Harvard Business School, reflecting a strong educational foundation that complements their extensive industry expertise.
Location
San Francisco, United States
Links
This person is not in the org chart
This person is not in any teams
This person is not in any offices